These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 34291376)

  • 21. Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose.
    Nevo L; Cahen-Peretz A; Vorontsov O; Frenkel R; Kabessa M; Cohen SM; Hamrani A; Oiknine-Djian E; Lipschuetz M; Goldman-Wohl D; Walfisch A; Kovo M; Neeman M; Yagel S; Wolf DG; Beharier O
    Am J Obstet Gynecol; 2022 Sep; 227(3):486.e1-486.e10. PubMed ID: 35430228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine.
    Maron JS; Conroy M; Naranbai V; Samarakoon U; Motazedi T; Farmer JR; Freeman E; Banerji A; Bartsch YC; Gregory DJ; Poznansky MC; Alter G; Blumenthal KG
    J Infect Dis; 2022 Sep; 226(7):1231-1236. PubMed ID: 35325158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocarditis Following SARS-CoV2 mRNA Vaccination Against COVID-19: Facts and Open Questions.
    Heymans S; Dawson D; Fuster V; Metra M; Tocchetti CG
    J Am Coll Cardiol; 2022 Oct; 80(14):1363-1365. PubMed ID: 36175054
    [No Abstract]   [Full Text] [Related]  

  • 24. Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines.
    Nascimento Júnior JAC; Santos AM; Cavalcante RCM; Quintans-Júnior LJ; Walker CIB; Borges LP; Frank LA; Serafini MR
    Drug Dev Ind Pharm; 2021 Apr; 47(4):673-684. PubMed ID: 33826439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects: An observational study.
    Grieco T; Maddalena P; Sernicola A; Muharremi R; Basili S; Alvaro D; Cangemi R; Rossi A; Pellacani G
    Dermatol Ther; 2021 Nov; 34(6):e15153. PubMed ID: 34622531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development.
    Wang F; Kream RM; Stefano GB
    Med Sci Monit; 2020 May; 26():e924700. PubMed ID: 32366816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV2 vaccine boosters for India.
    Kang G
    Indian J Med Microbiol; 2022; 40(1):1-2. PubMed ID: 34991914
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel.
    Swift MD; Breeher LE; Tande AJ; Tommaso CP; Hainy CM; Chu H; Murad MH; Berbari EF; Virk A
    Clin Infect Dis; 2021 Sep; 73(6):e1376-e1379. PubMed ID: 33900384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "COVID Arm": Very delayed large injection site reactions to mRNA COVID-19 vaccines.
    Ramos CL; Kelso JM
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2480-2481. PubMed ID: 33864927
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute polyradiculoneuropathy with SARS-CoV2 vaccines: Reply.
    Rajabally YA; Salim O; Loo LK
    Muscle Nerve; 2022 Nov; 66(5):E32-E33. PubMed ID: 36056615
    [No Abstract]   [Full Text] [Related]  

  • 31. Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.
    Bárczi E; Varga V; Nagy A; Eszes N; Jáky-Kováts Z; Müller V; Bohács A
    Immun Inflamm Dis; 2022 Aug; 10(8):e646. PubMed ID: 35894705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 vaccine effectiveness among the staff of the Bologna Health Trust, Italy, December 2020-April 2021.
    Giansante C; Stivanello E; Perlangeli V; Ferretti F; Marzaroli P; Musti MA; Pizzi L; Resi D; Saraceni S; Pandolfi P
    Acta Biomed; 2021 Sep; 92(4):e2021270. PubMed ID: 34487060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!
    Krantz MS; Bruusgaard-Mouritsen MA; Koo G; Phillips EJ; Stone CA; Garvey LH
    Allergy; 2021 Sep; 76(9):2916-2920. PubMed ID: 34028041
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE).
    Tran AP; Tassone D; Nossent J; Ding NS
    RMD Open; 2022 May; 8(1):. PubMed ID: 35577478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIV.
    Ruddy JA; Boyarsky BJ; Werbel WA; Bailey JR; Karaba AH; Garonzik-Wang JM; Segev DL; Durand CM
    AIDS; 2021 Sep; 35(11):1872-1874. PubMed ID: 33993131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan.
    Kitagawa H; Kaiki Y; Sugiyama A; Nagashima S; Kurisu A; Nomura T; Omori K; Akita T; Shigemoto N; Tanaka J; Ohge H
    J Infect Chemother; 2022 Apr; 28(4):576-581. PubMed ID: 35058126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination-a narrative review.
    Wollina U; Chiriac A; Kocic H; Koch A; Brzezinski P
    Wien Med Wochenschr; 2022 Mar; 172(3-4):63-69. PubMed ID: 34424434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 and mRNA Vaccines-First Large Test for a New Approach.
    Abbasi J
    JAMA; 2020 Sep; 324(12):1125-1127. PubMed ID: 32880613
    [No Abstract]   [Full Text] [Related]  

  • 39. Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals.
    Collier AY; Yu J; McMahan K; Liu J; Atyeo C; Ansel JL; Fricker ZP; Pavlakis M; Curry MP; Jacob-Dolan C; Patel H; Sellers D; Barrett J; Rowe M; Ahmad K; Gompers A; Aguayo R; Chandrashekar A; Alter G; Hacker MR; Barouch DH
    J Infect Dis; 2022 Apr; 225(7):1124-1128. PubMed ID: 34792136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PEG skin testing for COVID-19 vaccine allergy.
    Stone BD
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1765. PubMed ID: 33838847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.